ProfileGDS4814 / ILMN_1782558
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 1% 7% 7% 3% 2% 9% 16% 5% 6% 2% 19% 8% 2% 11% 7% 21% 30% 12% 7% 10% 7% 5% 10% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)36.20091
GSM780708Untreated after 4 days (C2_1)40.13887
GSM780709Untreated after 4 days (C3_1)40.03887
GSM780719Untreated after 4 days (C1_2)38.44453
GSM780720Untreated after 4 days (C2_2)37.88672
GSM780721Untreated after 4 days (C3_2)40.85099
GSM780710Trastuzumab treated after 4 days (T1_1)42.685816
GSM780711Trastuzumab treated after 4 days (T2_1)39.48245
GSM780712Trastuzumab treated after 4 days (T3_1)39.95366
GSM780722Trastuzumab treated after 4 days (T1_2)37.90262
GSM780723Trastuzumab treated after 4 days (T2_2)43.261519
GSM780724Trastuzumab treated after 4 days (T3_2)40.5598
GSM780713Pertuzumab treated after 4 days (P1_1)37.19522
GSM780714Pertuzumab treated after 4 days (P2_1)41.535911
GSM780715Pertuzumab treated after 4 days (P3_1)40.13887
GSM780725Pertuzumab treated after 4 days (P1_2)43.828921
GSM780726Pertuzumab treated after 4 days (P2_2)45.604230
GSM780727Pertuzumab treated after 4 days (P3_2)41.759412
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)40.33687
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)41.045710
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)40.37887
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)39.62935
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)41.136410